79902-63-9 Simvastatin 98%

Established in 1991, Krebs undertakes both contract manufacturing for large pharmaceutical and multinational companies and develops products for sale in global markets.  Krebs is listed on NSE and BSE in India and is headquartered in Hyderabad, India with manufacturing plants in Nellore and Vizag, India. 

Expertise and infrastructure in the areas of chemical synthesis, fermentation and enzymatic technologies along with a focus on cost and quality makes Krebs a logical partner for the development and supply of products made using one or more of these technologies.
Krebs ensures all its manufacturing is conducted in line with the current good manufacturing practices.  It adopts and implements the guidelines of ICH, APIC and other Regulatory Authorities.

Regulatory Authorities, customers and Certification Agencies periodically inspect Krebs’ Units.  Its Units have been successfully inspected by the USFDA, EDQM along with AFSSAPS and Norwegian Medicines Agency.  ISO and WHO GMP are other certifications achieved.